Related Experiment Video

Updated: Jun 13, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Overview of novel therapeutic targets for asthma and chronic obstructive pulmonary disease

Fulvio Braido1, Silvia Brandi, Sara Cauglia

  • 1University of Genoa, Allergy & Respiratory Diseases, Department of Medical Specialties, San Martino Hospital, Italy. fulvio.braido@unige.it

Expert Review of Clinical Immunology
|May 19, 2010
PubMed

Insights

Asthma and chronic obstructive pulmonary disease (COPD) management requires new strategies targeting inflammation to slow disease progression. This review explores promising therapeutic targets for these widespread obstructive lung diseases.

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Immunology

Background:

  • Obstructive lung diseases like asthma and COPD are globally prevalent and increasing.
  • Current treatments manage symptoms but do not halt disease progression.
  • Inflammatory responses are key in the pathogenesis of chronic lung obstruction.

Purpose of the Study:

  • To review clinically and pharmacologically relevant therapeutic targets for asthma and COPD.
  • To discuss current and emerging treatment strategies for these conditions.

Main Methods:

  • Literature review of pathogenetic studies.
  • Analysis of molecular findings related to inflammation in obstructive lung diseases.
  • Overview of current therapeutic approaches and targets.

Main Results:

  • Inflammation is a critical factor in the development of obstructive lung diseases.
  • Numerous molecular targets for therapeutic intervention have been identified.
  • Several promising therapeutic approaches are under investigation.

Conclusions:

  • Targeting inflammatory pathways offers potential for modifying disease progression in asthma and COPD.
  • Further research into these targets could lead to more effective treatments.
  • A comprehensive understanding of therapeutic targets is crucial for advancing patient care.

More Related Videos

Generation of Human 3D Lung Tissue Cultures (3D-LTCs) for Disease Modeling05:47

Generation of Human 3D Lung Tissue Cultures (3D-LTCs) for Disease Modeling

Published on: February 12, 2019

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: